News from GUERBET A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 10, 2014, 12:00 ET

FDA Approves Lipiodol® (Ethiodized Oil) Injection for Imaging of Tumors in Adults with Known Hepatocellular Carcinoma (HCC)

 Guerbet, a pioneer in the field of contrast agents for medical imaging announced that Lipiodol® was approved by the US Food and Drug...

Mar 26, 2014, 10:54 ET

Sirtex und Guerbet arbeiten bei Studien zu primärem und sekundärem Leberkrebs zusammen

Sirtex Medical Limited (ASX: SRX) und Guerbet SA (EPA: GBT) gaben am Montag ihre umfassende Zusammenarbeit bei klinischen Studien zum...

Mar 26, 2014, 03:00 ET

Sirtex y Guerbet colaboran en estudios clínicos sobre cáncer hepático primario y secundario

 No distribuir en EE. UU.  Sirtex Medical Limited (ASX:SRX) y Guerbet S.A. (EPA:GBT) anuncian hoy que las dos...

Mar 25, 2014, 17:44 ET

Sirtex y Guerbet colaboran en estudios clínicos sobre cáncer hepático primario y secundario

Sirtex Medical Limited (ASX:SRX) y Guerbet S.A. (EPA:GBT) anuncian hoy que las dos compañías iniciarán una...

Mar 25, 2014, 06:34 ET

Sirtex e Guerbet acertam colaboração para estudos clínicos sobre câncer primário e secundário de fígado

A Sirtex Medical Limited (ASX:SRX) e a Guerbet S.A. (EPA:GBT) anunciaram hoje que as duas empresas irão realizar um grande trabalho de...

Mar 24, 2014, 11:25 ET

Sirtex and Guerbet Announce Collaboration On Clinical Studies in Liver Cancer

Sirtex Medical Limited (ASX: SRX) and Guerbet S.A. (GBT.PA) are pleased to announce today that the two companies are entering into a collaboration...

Mar 24, 2014, 08:00 ET

Sirtex and Guerbet Announce Collaboration On Clinical Studies in Liver Cancer

Sirtex Medical Limited (ASX: SRX) and Guerbet S.A. (GBT.PA) are pleased to announce today that the two companies are entering into a collaboration...

Mar 24, 2014, 03:00 ET

Sirtex et Guerbet vont mener en collaboration des études cliniques sur le cancer du foie primitif et secondaire

 Sirtex Medical Limited (ASX:SRX) et Guerbet S.A. (EPA:GBT) annoncent aujourd'hui qu'elles vont mener en collaboration des études...

Mar 07, 2014, 02:00 ET

FlowSens®: eine Lösung der neuen Generation für die CT-Bildgebung

Mit dieser einzigartigen und innovativen Lösung, die zum ersten Mal auf dem Europäischen Kongress für Radiologie (ECR) in Wien vom...

Mar 07, 2014, 02:00 ET

FlowSens® : une solution de nouvelle génération pour l'imagerie Rayons X

Présentée pour la première fois à l'occasion du congrès européen de radiologie (ECR, Vienne, 7-10 mars 2014), cette...

Feb 19, 2014, 14:00 ET

Guerbet Receives FDA Approval for a New Manufacturing Plant for Lipiodol® (ethiodized oil) Injection

 Guerbet (GBT), the contrast agent specialist for medical imaging, today announced that it had received approval from the U.S. Food and Drug...

Nov 06, 2013, 12:05 ET

Dotarem® (gadoterate meglumine) Injection Now Offered Via Innovative Technology Agreement Awarded By Novation

Guerbet announced today that Novation, the leading health care supply chain expertise, analytics and contracting company, has awarded a new...

Oct 21, 2013, 12:06 ET

FDA Grants Orphan Drug Designation to Lipiodol® (Ethiodized Oil) Injection for Management of Patients with Known Hepatocellular Carcinoma (HCC)

 Guerbet LLC, USA -- Guerbet, a pioneer in the field of contrast agents with more than 80 years of experience, announced that it has...

Jul 25, 2013, 12:45 ET

First Injection of Dotarem® (gadoterate meglumine) in US Performed at Cincinnati Children's Hospital Medical Center

 Guerbet announced today that Cincinnati Children's Hospital Medical Center (Cincinnati Children's) last week performed the first US injection...

Apr 11, 2013, 08:23 ET

La FDA aprobó el Dotarem® (gadoterato de meglumina), primer medio de contraste macrocíclico e iónico basado en gadolinio de los Estados Unidos

Guerbet anunció hoy que la Administración de Fármacos y Alimentos estadounidense (Food and Drug Administration, FDA) aprobó el...

Apr 11, 2013, 07:30 ET

FDA aprova Dotarem® (ácido gadotérico), primeiro agente de contraste macrocíclico e iônico à base de gadolínio dos EUA

 Guerbet anunciou hoje que o FDA (US Food and Drug Administration) aprovou  Dotarem® (ácido gadotérico), um agente de...

Apr 02, 2013, 02:24 ET

La FDA aprueba Dotarem® (ácido gadotérico)

- La FDA aprueba Dotarem® (ácido gadotérico), el primer agente de contraste iónico macrocíclico basado en...

Mar 29, 2013, 05:13 ET

FDA erteilt Zulassung für Dotarem® (Gadotersäure), das erste makrozyklische und ionische gadoliniumhaltige Kontrastmittel in den USA

Guerbet gab heute bekannt, dass die US Food und Drug Administration (FDA) die Zulassung für Dotarem® (Gadotersäure), ein...

Mar 28, 2013, 09:46 ET

La FDA approva Dotarem® (gadoterate meglumine), il primo agente di contrasto macrociclico ionico a base di gadolinio negli USA

Guerbet ha annunciato oggi che la US Food and Drug Administration (FDA) ha approvato Dotarem® (gadoterate meglumine), mezzo di contrasto a...

Mar 27, 2013, 13:00 ET

La FDA autorise Dotarem® (gadotérate de méglumine), premier produit de contraste macrocyclique et ionique à base de gadolinium aux Etats-Unis

Guerbet, spécialiste des produits de contraste pour l'imagerie médicale, annonce que la Food and Drug Administration (FDA)...